Based inside the REDIzone incubator on the Northeast Ohio Medical University campus, BioMendics develops investigational medicines for rare dermatologic disorders, led by a small-molecule liquid-crystal platform aimed at repairing fragile, blistering skin. Founded by scientists, physicians, and angel investors, the company is currently advancing its topical TolaSure gel through a Phase II study for epidermolysis bullosa simplex. CEO and founder Karen M. McGuire, PhD, brings more than 15 years of drug-development experience to the research program.
Current Good Manufacturing Practice (cGMP)
compliance_program
Good Laboratory Practice (GLP)
compliance_program
FDA Fast Track Designation
compliance_program
Alphyn BiologicsFounded by a team led by the scientist who helped develop Bactroban, Alphyn Biologics is a clinical-stage dermatology company developing topical medicines for difficult skin diseases. Based in Annapolis and Cincinnati, the company’s botanical Zabalafin Platform uses multiple bioactive compounds to address several disease drivers at once, with lead programs targeting atopic dermatitis and molluscum contagiosum. Alphyn became operational in 2020 and has wholly owned subsidiaries in Australia and Austria.
Soriya, LLCSoriya, LLC is a Philadelphia startup developing products for people with chronic skin diseases. It was co-founded by medical and industrial design students from Thomas Jefferson University.BALA-CYNWYD, PA
Velius, LLCVelius, LLC is a research-driven biopharmaceutical company developing prescription and over-the-counter medicines that target or are delivered through the skin. Founded and built by medical professionals, the Great Neck company is led by a surgeon and a pharmacist and has built its portfolio around nanotechnology-enabled film delivery, including products for scar treatment and dermatological conditions. Its intellectual-property portfolio includes patents issued in more than 25 countries and a suite of 19 developed pharmaceuticals.GREAT NECK, NY
NeuEsse IncNeuEsse Inc. develops plant-based skin-repair technology, led by its soy-protein OmegaSkin™ human skin substitute for wounds, burns and other injuries. Based in Dunbar, Pennsylvania, the company also is developing a liquid skin formulation and a handheld electrospinner intended to deliver treatments without refrigeration, special handling or direct-touch application. Founder and CEO Joe Connell brings more than 38 years of pharmaceutical and biotechnology experience to the venture.339113DUNBAR, PA